| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Tomomi Ide | |
| Karine Egan | |||
| Garret A. FitzGerald | |||
| L. Chastine Bell-Parikh | |||
| P2860 | cites work | Identification of the platelet ADP receptor targeted by antithrombotic drugs | Q24290845 |
| Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 | Q24290855 | ||
| The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling | Q24530668 | ||
| Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta) | Q24553125 | ||
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | Q24555072 | ||
| Genetic and pharmacological analysis of prostanoid receptor function | Q28186062 | ||
| Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 | ||
| Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3 | Q28513448 | ||
| Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 | Q28585904 | ||
| 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma | Q29615221 | ||
| A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation | Q29619212 | ||
| Thioredoxin as a molecular target of cyclopentenone prostaglandins. | Q31140124 | ||
| Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists | Q33376803 | ||
| Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase | Q33886831 | ||
| The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras | Q34189442 | ||
| Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice | Q34730034 | ||
| A novel pathway of prostacyclin signaling-hanging out with nuclear receptors | Q34794807 | ||
| 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. | Q35698498 | ||
| Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma | Q35919761 | ||
| Prostaglandin endoperoxide synthase: structure and catalysis | Q37334573 | ||
| Regulatory role of cyclic adenosine 3′,5′-monophosphate on the plattelet cyclooxygenase and platelet function | Q40202800 | ||
| 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes | Q40757735 | ||
| Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. | Q40797404 | ||
| Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages | Q40841282 | ||
| Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. | Q40978901 | ||
| The PPARalpha-leukotriene B4 pathway to inflammation control. | Q42552721 | ||
| Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy | Q42830105 | ||
| Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction | Q44196710 | ||
| 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. | Q44255012 | ||
| Inducible cyclooxygenase may have anti-inflammatory properties | Q61053473 | ||
| Prostaglandin D2 as a mediator of allergic asthma | Q73556211 | ||
| The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2). A putative L-shaped binding conformation utilizing the top channel region | Q78101756 | ||
| P433 | issue | 5-6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 311-315 | |
| P577 | publication date | 2003-06-01 | |
| 2003-06-15 | |||
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Activation of nuclear receptors by prostaglandins | |
| P478 | volume | 110 |
| Q33451846 | 11-Oxoeicosatetraenoic acid is a cyclooxygenase-2/15-hydroxyprostaglandin dehydrogenase-derived antiproliferative eicosanoid |
| Q34049297 | 15-Deoxy-Δ¹²,¹⁴ prostaglandin J₂ reduces the formation of atherosclerotic lesions in apolipoprotein E knockout mice |
| Q42576987 | An interaction between L-prostaglandin D synthase and arrestin increases PGD2 production |
| Q90736467 | Analysis of the uterine lumen in fertility-classified heifers: I. Glucose, prostaglandins, and lipids† |
| Q36775280 | Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases |
| Q28391506 | Basic principles and emerging concepts in the redox control of transcription factors |
| Q64325520 | Bicyclic eremophilane-type petasite sesquiterpenes potentiate peroxisome proliferator-activated receptor γ activator-mediated inhibition of dendritic cells |
| Q35778758 | Cell signalling by reactive lipid species: new concepts and molecular mechanisms |
| Q33458922 | Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid |
| Q24323350 | Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase theta facilitates induction of CYP17 |
| Q51042965 | Early increase in alveolar macrophage prostaglandin 15d-PGJ2 precedes neutrophil recruitment into lungs of cytokine-insufflated rats. |
| Q35909254 | Health implications of high dietary omega-6 polyunsaturated Fatty acids. |
| Q30573092 | Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ. |
| Q35808814 | PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome |
| Q40111521 | Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression. |
| Q37043505 | Pharmacogenetics of the constitutive androstane receptor |
| Q58869382 | Prostanoid function and cardiovascular disease |
| Q36617121 | The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. |
| Q26999707 | The role of the EP receptors for prostaglandin E2 in skin and skin cancer |
| Q92941365 | Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation |
| Q37988008 | Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism |
Search more.